These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23162074)

  • 21. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
    Umelo IA; Costanza B; Castronovo V
    Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Biomarker Discovery for Precision Medicine: New Progress.
    Zou J; Wang E
    Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inconvenient truth: cancer biomarker development by using proteomics.
    Kondo T
    Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteome Heterogeneity in Colorectal Cancer.
    Lim LC; Lim YM
    Proteomics; 2018 Feb; 18(3-4):. PubMed ID: 29316255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics as a guiding tool for more effective personalized therapy.
    Lee JM; Kohn EC
    Ann Oncol; 2010 Oct; 21 Suppl 7(Suppl 7):vii205-10. PubMed ID: 20943616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum proteomics in biomedical research: a systematic review.
    Zhang AH; Sun H; Yan GL; Han Y; Wang XJ
    Appl Biochem Biotechnol; 2013 Jun; 170(4):774-86. PubMed ID: 23609910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist.
    Kim J; Jin P; Yang W; Kim WJ
    Investig Clin Urol; 2020 Nov; 61(6):539-554. PubMed ID: 33135400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular insights into cancer drug resistance from a proteomics perspective.
    An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the endogenous peptidomes of cancer for biomarkers: A new endeavor.
    Lee PY; Low TY; Jamal R
    Adv Clin Chem; 2019; 88():67-89. PubMed ID: 30612607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics in cancer research: Are we ready for clinical practice?
    Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical potential of mass spectrometry-based proteogenomics.
    Zhang B; Whiteaker JR; Hoofnagle AN; Baird GS; Rodland KD; Paulovich AG
    Nat Rev Clin Oncol; 2019 Apr; 16(4):256-268. PubMed ID: 30487530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
    Clarke W; Chan DW
    Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic research progress in lymphatic metastases of cancers.
    Zong J; Guo C; Liu S; Sun MZ; Tang J
    Clin Transl Oncol; 2012 Jan; 14(1):21-30. PubMed ID: 22262715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.